Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DHR

Danaher Corp

Sep 15 • 02:38PM ET

188.38

-1.67 -0.88 %

Healthcare • Diagnostics & Research • USA • NYSE

Peers: GE HON MMM ROK KEYS ABT TMO MTD BSX

| Held by: VTI VOO SPY IVV VTV XLV VIG VHT JEPI MOAT

Scroll to Statements

Index	S&P 500	P/E	40.01	EPS (ttm)	4.71	Insider Own	8.91%	Shs Outstand	715.90M	Perf Week	-5.16%
Market Cap	134.89B	Forward P/E	21.93	EPS next Y	8.59	Insider Trans	-1.95%	Shs Float	652.28M	Perf Month	-10.39%
Enterprise Value	150.50B	PEG	4.88	EPS next Q	1.72	Inst Own	81.90%	Short Float	1.46%	Perf Quarter	-6.12%
Income	3.41B	P/S	5.62	EPS this Y	3.97%	Inst Trans	0.12%	Short Ratio	2.48	Perf Half Y	-10.61%
Sales	24.01B	P/B	2.58	EPS next Y	10.46%	ROA	4.26%	Short Interest	9.55M	Perf YTD	-17.94%
Book/sh	73.10	P/C	45.62	EPS next 5Y	8.20%	ROE	6.68%	52W High	279.90 -32.70%	Perf Year	-30.74%
Cash/sh	4.13	P/FCF	27.74	EPS past 3/5Y	-15.01% 9.03%	ROIC	4.93%	52W Low	171.00 10.16%	Perf 3Y	-26.23%
Dividend Est.	1.25 (0.66%)	EV/EBITDA	19.87	Sales past 3/5Y	-6.76% 5.92%	Gross Margin	61.52%	Volatility	2.48% 2.29%	Perf 5Y	8.35%
Dividend TTM	1.18 (0.63%)	EV/Sales	6.27	EPS Y/Y TTM	-16.60%	Oper. Margin	21.59%	ATR (14)	4.96	Perf 10Y	227.61%
Dividend Ex-Date	Sep 26, 2025	Quick Ratio	1.22	Sales Y/Y TTM	-3.24%	Profit Margin	14.21%	RSI (14)	33.39	Recom	1.32
Dividend Gr. 3/5Y	8.74% 9.69%	Current Ratio	1.62	EPS Q/Q	-36.83%	SMA20	-6.74%	Beta	0.78	Target Price	242.48
Payout	20.42%	Debt/Eq	0.35	Sales Q/Q	3.36%	SMA50	-6.18%	Rel Volume	0.93	Prev Close	190.05
Employees	63000	LT Debt/Eq	0.32	Earnings	Jul 22 BMO	SMA200	-9.44%	Avg Volume	3.86M	Price	188.38
IPO	Dec 10, 1969	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.53% 1.68%	Trades		Volume	2,859,134	Change	-0.88%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-11-25	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$275
Apr-10-25	Upgrade	Barclays	Equal Weight → Overweight	$205
Mar-21-25	Upgrade	Goldman	Neutral → Buy	$260
Mar-14-25	Upgrade	Stifel	Hold → Buy	$260
Feb-03-25	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-23-24	Initiated	Scotiabank	Sector Perform
Dec-19-24	Initiated	Guggenheim	Buy	$275
Dec-13-24	Upgrade	BofA Securities	Neutral → Buy	$290
Oct-31-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$285
Oct-01-24	Initiated	Stephens	Overweight	$315
Aug-28-24	Initiated	Wells Fargo	Equal Weight	$280
Jun-03-24	Resumed	Jefferies	Buy	$295
Apr-17-24	Upgrade	HSBC Securities	Hold → Buy	$280
Jan-24-24	Downgrade	Barclays	Overweight → Equal Weight	$240
Dec-18-23	Initiated	HSBC Securities	Hold
Dec-13-23	Resumed	Wolfe Research	Peer Perform
Dec-07-23	Downgrade	Goldman	Buy → Neutral	$215 → $205
Jul-19-23	Initiated	Raymond James	Outperform	$270
May-01-23	Initiated	SVB Securities	Outperform	$300
Apr-26-23	Downgrade	BofA Securities	Buy → Neutral	$310 → $250

Show Previous Ratings

Today 09:00AM	Hologic's Breast Health Rebound in Motion: How to Play the Stock Now? (Zacks)
Sep-14-25 11:31PM	Unpacking Q2 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks (StockStory)
Sep-11-25 11:52AM	Danaher's Biotechnology Growth Picks Up: A Sign of More Upside? (Zacks)
Sep-10-25 08:31AM	Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research (PR Newswire)
Sep-09-25 04:15PM	Danaher Announces Quarterly Dividend (PR Newswire)
12:33AM	Loading…
Sep-08-25 12:33AM	3 Healthcare Stocks We're Skeptical Of (StockStory)
Sep-02-25 11:24AM	Danaher Gains From Business Strength Amid Persisting Headwinds (Zacks)
Sep-01-25 11:01AM	Is Danaher Stock Underperforming the Dow? (Barchart)
Aug-28-25 11:30AM	Why Is Teladoc (TDOC) Up 4.6% Since Last Earnings Report? (Zacks)
Aug-22-25 07:52AM	Is Danaher Corporation (DHR) a Quality Compounder With Long-Term Revenue Growth? (Insider Monkey)
Aug-21-25 11:30AM	Danaher (DHR) Up 6.8% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-18-25 09:30AM	Danaher (DHR) Just Overtook the 200-Day Moving Average (Zacks)
Aug-17-25 02:14AM	Wells Fargo Reduces PT on Danaher Corporation (DHR) to $205; Maintains 'Equal Weight' Rating (Insider Monkey)
Aug-14-25 11:42AM	Are Wall Street Analysts Predicting Danaher Stock Will Climb or Sink? (Barchart)
Aug-13-25 12:43PM	Is it a Great Time to Invest in Danaher Corp. (DHR)? (Insider Monkey)
10:11AM	Loading…
10:11AM	Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi (GlobeNewswire)
08:41AM	Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge (GlobeNewswire)
Aug-12-25 10:30PM	[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
08:30AM	Genedata Next-Gen Software to Power GMP-Compliant NGS in Biopharma Manufacturing (PR Newswire)
04:49AM	STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories (GlobeNewswire)
Aug-11-25 11:40AM	CVS or DHR: Which Is the Better Value Stock Right Now? (Zacks)
Aug-08-25 08:43AM	Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It? (Zacks)
Aug-04-25 09:00AM	AstroNova Appoints Jorik E. Ittmann as President and Chief Executive Officer (Business Wire)
Aug-01-25 04:50PM	Buy Graham Holdings Stock. Its Parts Are Worth More Than the Whole. (Barrons.com)
12:39PM	Markel's Q2 Earnings Surpass Estimates, Premiums Rise Y/Y (Zacks)
Jul-31-25 04:15PM	Danaher Appoints Jonathan Leiken as General Counsel (PR Newswire)
Jul-30-25 07:22AM	Aldevron Launches New Innovation Center in Waltham, MA (Business Wire)
05:08AM	Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic (GlobeNewswire)
04:20AM	Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever (Motley Fool)
03:37AM	Jim Cramer on Danaher: "I Think We've Finally Reached the Tipping Point" (Insider Monkey)
04:13PM	Loading…
Jul-29-25 04:13PM	Danaher Corporation (DHR): Maybe It Can Be Great Again, Says Jim Cramer (Insider Monkey)
01:43PM	Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report (PR Newswire)
04:00AM	Where this large cap portfolio manager see opportunity now (Yahoo Finance Video)
01:31AM	5 Revealing Analyst Questions From Danaher's Q2 Earnings Call (StockStory)
Jul-28-25 10:45AM	International Markets and Danaher (DHR): A Deep Dive for Investors (Zacks)
Jul-26-25 07:44PM	Danaher Corporation (DHR)'s Been A Disaster, Says Jim Cramer (Insider Monkey)
Jul-25-25 11:28PM	UBS Lowers PT on Danaher Corporation (DHR) to $225 From $240, Keeps a Buy Rating (Insider Monkey)
09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-24-25 08:35PM	Investors decided the good outweighs the bad with Danaher, says Jim Cramer (CNBC TV)
01:38PM	Contract research firms' strong earnings signal stabilizing biotech, pharma spending (Reuters)
11:40AM	CVS or DHR: Which Is the Better Value Stock Right Now? (Zacks)
Jul-23-25 09:45AM	Here's Why Danaher (DHR) is a Strong Growth Stock (Zacks)
06:46AM	Thermo Fisher flags improving tariff situation, raises annual profit view (Reuters)
03:04AM	Danaher Corp (DHR) Q2 2025 Earnings Call Highlights: Strong Cash Flow and Bioprocessing Growth ... (GuruFocus.com)
Jul-22-25 03:14PM	Stocks to Watch Tuesday: Kohls, Lockheed Martin, Coca-Cola, GM (The Wall Street Journal)
02:05PM	Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline (Benzinga)
12:02PM	Steven Cohen's Strategic Moves: A Closer Look at Danaher Corp's Impact on His Portfolio (GuruFocus.com)
11:26AM	Cramer's Stop Trading: Danaher (CNBC TV)
11:15AM	Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y (Zacks)
10:28AM	Analyst Report: Danaher Corporation (Morningstar Research)
10:12AM	Stocks to Watch Tuesday: RTX, Lockheed Martin, Coca-Cola, GM (The Wall Street Journal)
09:30AM	Danaher (DHR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:10AM	Danaher (DHR) Q2 Earnings and Revenues Top Estimates (Zacks)
06:40AM	Danaher shares slip despite Q2 beat, annual profit outlook hike (Investing.com)
06:08AM	Danaher: Q2 Earnings Snapshot (Associated Press Finance)
06:07AM	Danaher's (NYSE:DHR) Q2 Sales Top Estimates But Quarterly Revenue Guidance Slightly Misses Expectations (StockStory)
06:02AM	Danaher Announces Transition Plan for Chief Financial Officer (PR Newswire)
06:00AM	Danaher Reports Second Quarter 2025 Results (PR Newswire)
03:36AM	Alphabet and Tesla Earnings, Home Sales and More: What to Watch This Week (The Wall Street Journal)
Jul-21-25 06:02AM	India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher (GlobeNewswire)
03:27AM	Alphabet and Tesla Earnings, Powell Speech and More: What to Watch This Week (The Wall Street Journal)
Jul-20-25 11:07PM	Danaher (DHR) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
01:15PM	Donald Trump faces frosty reception on Aberdeen golf trip (Financial Times)
Jul-19-25 06:08AM	Too Cheap to Ignore: Scotiabank Says Theres an Opportunity Brewing in These 2 Large Cap Healthcare Stocks (TipRanks)
Jul-18-25 03:51PM	Alphabet and Tesla Earnings, Powell Speech and More: What to Watch Next Week (The Wall Street Journal)
11:26AM	Danaher Gears Up to Post Q2 Earnings: What Lies Ahead for the Stock? (Zacks)
10:32AM	Medical Filtration Company Benchmark Report 2025 \| Merck KGaA, 3M, and Danaher Strengthen Medical Filtration Market Leadership Through Strategic Expansions, Spin-Offs, and Mergers (GlobeNewswire)
Jul-17-25 09:15AM	Danaher (DHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Jul-16-25 04:07AM	Saudi Arabia In-Vitro Diagnostics Market Report 2025-2030 Featuring Abbott, BD, Bio-Rad Laboratories, Biomerieux, Danaher, Nihon Kohden, Roche, Siemens Healthineers, Sysmex, Thermo Fischer Scientific (GlobeNewswire)
Jul-13-25 02:48AM	Danaher (DHR) Teams Up to Advance Precision Medicine Diagnostics (Insider Monkey)
Jul-11-25 09:38AM	CoreWeave initiated, Texas Instruments upgraded: Wall Street's top analyst calls (The Fly)
Jul-08-25 06:24AM	Liquid Handling Systems Market Insights Report 2025-2030 \| Advancements in Microplate Reagent Dispensers, Transformation in Genomics, Importance in Drug Discovery & Development, Lab Automation (GlobeNewswire)
Jul-05-25 10:43AM	Jim Cramer Says "Danaher Can Make a Comeback" (Insider Monkey)
Jul-03-25 04:21AM	Biopharmaceuticals Manufacturing Consumables Testing Market 2025-2030: Thermo Fisher Scientific, Danaher Corporation, and Merck Lead (GlobeNewswire)
Jul-01-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
Jun-30-25 11:34AM	Is Danaher's M&A Premium Already Priced In? (GuruFocus.com)
01:09AM	Danaher appoints Martin Stumpe as chief technology and AI officer (MedTech Dive)
Jun-28-25 12:20PM	Jim Cramer on Danaher: "This Stock Has Been Such a Disappointment for Me" (Insider Monkey)
Jun-27-25 11:40AM	CVS vs. DHR: Which Stock Is the Better Value Option? (Zacks)
07:35AM	Danaher Appoints Martin Stumpe as Chief Technology and AI Officer (PR Newswire)
07:30AM	Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences (PR Newswire)
Jun-25-25 09:01PM	Lightning Round: I am horrified at what is happening at Danaher, says Jim Cramer (CNBC TV)
12:27PM	Opus Water Launches -- Serving the Water, Wastewater and Industrial Process Fluids Industries (PR Newswire)
12:23PM	Danaher Corporation (DHR) Is "Fool's Gold," Bemoans Jim Cramer (Insider Monkey)
10:47AM	Oligonucleotide Synthesis Market Research and Global Forecast Report 2025-2030: Rising Emphasis on Advancing Drug Delivery and Scalable Synthesis Technologies for Oligonucleotide-Based Therapeutics (GlobeNewswire)
Jun-24-25 11:52AM	Danaher Corporation (DHR): A Bull Case Theory (Insider Monkey)
Jun-20-25 09:45AM	Why Danaher (DHR) is a Top Growth Stock for the Long-Term (Zacks)
Jun-17-25 04:30PM	Danaher Schedules Second Quarter 2025 Earnings Conference Call (PR Newswire)
12:10PM	5 Must-Read Analyst Questions From Danaher's Q1 Earnings Call (StockStory)
Jun-13-25 04:31PM	Top Analyst Reports for Eli Lilly, Home Depot & SAP (Zacks)
Jun-11-25 11:40AM	CVS vs. DHR: Which Stock Should Value Investors Buy Now? (Zacks)
02:00AM	Tesla Stock Has Lost Its Trump Bump. How to Play the Shares Now. (Barrons.com)
Jun-05-25 12:02AM	3 Reasons to Avoid DHR and 1 Stock to Buy Instead (StockStory)
Jun-02-25 07:00AM	Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations (Business Wire)
07:00AM	SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations (Business Wire)
07:00AM	SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement (Business Wire)
May-30-25 11:50AM	Danaher Partners With AstraZeneca to Support Precision Medicine (Zacks)
10:12AM	Danaher and AstraZeneca to develop diagnostic tools and tests (Medical Device Network)
May-29-25 11:11PM	Danaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine Tests (Insider Monkey)
04:30PM	Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine (PR Newswire)

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
List Teri	Director	Aug 22 '25	Sale	211.06	2,778	586,319	20,751	Aug 25 05:00 PM
List Teri	Director	Aug 22 '25	Proposed Sale	211.06	2,778	586,320		Aug 22 12:18 PM
LOHR WALTER G	Former Director	Jul 22 '25	Proposed Sale	188.15	2,719	511,588		Jul 22 11:49 AM
Zerhouni Elias A.	Director	Jul 15 '25	Option Exercise	59.34	3,928	233,088	42,014	Jul 16 05:01 PM
SCHWIETERS JOHN T	Director	Jul 15 '25	Option Exercise	59.34	3,928	233,088	21,024	Jul 16 05:01 PM
List Teri	Director	Jul 02 '25	Option Exercise	59.34	3,928	233,088	24,667	Jul 07 05:00 PM
RALES STEVEN M	Chairman	May 12 '25	Sale	196.74	1,250,000	245,919,391	3,105,808	May 14 05:19 PM
RALES STEVEN M	Officer	May 12 '25	Proposed Sale	194.82	1,250,000	243,525,000		May 12 09:30 PM
Raskas Daniel	Former Officer	May 02 '25	Proposed Sale	201.03	7,053	1,417,865		May 02 10:45 AM
Riley Christopher Paul	Executive Vice President	Apr 30 '25	Option Exercise	76.47	7,801	596,542	30,984	May 01 05:01 PM
Riley Christopher Paul	Executive Vice President	Apr 30 '25	Sale	198.00	15,805	3,129,424	15,179	May 01 05:01 PM
Riley Christopher Paul	Officer	Apr 30 '25	Proposed Sale	198.00	15,805	3,129,421		Apr 30 03:41 PM
Glenstone Foundation	See Remarks	Apr 24 '25	Proposed Sale	196.50	598,281	117,562,216		Apr 24 05:28 PM
King William	Former Officer	Mar 11 '25	Proposed Sale	207.14	64,697	13,401,340		Mar 11 04:03 PM
King William	Officer	Feb 21 '25	Proposed Sale	209.97	114,351	24,010,531		Feb 21 04:18 PM
Sabeti Pardis C	former Board of Directors	Feb 18 '25	Proposed Sale	204.28	4,337	885,953		Feb 18 01:04 PM
SPOON ALAN G	Director	Feb 07 '25	Option Exercise	59.34	3,928	233,088	121,068	Feb 10 05:00 PM
SPOON ALAN G	Director	Feb 07 '25	Sale	206.46	550	113,553	120,518	Feb 10 05:00 PM
SPOON ALAN G	Director	Feb 07 '25	Proposed Sale	206.46	550	113,553		Feb 07 03:34 PM
Ellis Brian W	Senior Vice President - GC	Jan 30 '25	Option Exercise	58.59	5,700	333,963	25,930	Jan 31 05:00 PM
Ellis Brian W	Senior Vice President - GC	Jan 30 '25	Sale	224.13	5,700	1,277,541	20,230	Jan 31 05:00 PM
Ellis Brian W	Officer	Jan 30 '25	Proposed Sale	224.13	5,700	1,277,542		Jan 30 12:56 PM
Raskas Daniel	SVP - Corporate Development	Nov 26 '24	Option Exercise	58.59	26,318	1,541,972	41,543	Nov 27 05:01 PM
Raskas Daniel	SVP - Corporate Development	Nov 26 '24	Sale	236.59	26,318	6,226,497	15,225	Nov 27 05:01 PM
Raskas Daniel	SVP - Corporate Development	Nov 25 '24	Sale	238.00	8,370	1,992,060	15,225	Nov 27 05:01 PM
Raskas Daniel	Officer	Nov 26 '24	Proposed Sale	236.59	26,318	6,226,496		Nov 26 04:40 PM
Raskas Daniel	Officer	Nov 25 '24	Proposed Sale	238.00	8,370	1,992,060		Nov 25 12:04 PM
Glenstone Foundation	See Remarks	Nov 05 '24	Proposed Sale	247.76	100,000	24,776,000		Nov 05 04:01 PM
Weidemanis Joakim	Former Director	Oct 23 '24	Proposed Sale	254.95	17,659	4,502,216		Oct 23 01:10 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DHR

Danaher Corp

Upgrade your FINVIZ experience